2022
DOI: 10.1016/j.snb.2022.131826
|View full text |Cite
|
Sign up to set email alerts
|

Rational design of a highly selective UGT1A1 probe and its application in drug discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…13 Nilotinib was certified to be a potent inhibitor of UGT1A1 (approximately 95% inhibition). 31,41 We altered the UGT1A1 levels with chrysin and nilotinib to study the effect of the UGT1A1 level changes on Panc-1 cells. Before imaging, all experimental cells were incubated with BCy-Panc (10 μM) at 37 °C for 120 min.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…13 Nilotinib was certified to be a potent inhibitor of UGT1A1 (approximately 95% inhibition). 31,41 We altered the UGT1A1 levels with chrysin and nilotinib to study the effect of the UGT1A1 level changes on Panc-1 cells. Before imaging, all experimental cells were incubated with BCy-Panc (10 μM) at 37 °C for 120 min.…”
Section: Resultsmentioning
confidence: 99%
“…29 We designed and prepared the UGT1A1 probe BCy-panc by adding ortho chloride substitution next to the phenolic hydroxyl group of benzoindocyanine, which showed extremely high substrate conversion. 31 In organisms, UGTIA1 catalyses the conjugation of glucuronic acid molecules from uridine diphosphate-glucuronide (UDPGA) to various compounds to form water-soluble glucuronic acid, which increases the water-solubility of the compounds. [37][38][39][40] In the presence of UDPGA, UGT1A1-mediated o-glucuronidation of BCy-panc can trigger the fluorescent "turn-on" switch (Scheme 1).…”
Section: Design Strategies For Bcy-panc Probesmentioning
confidence: 99%
See 2 more Smart Citations
“…This process plays an important role in the metabolic clearance of clinical drugs in vivo. [37][38][39][40] In addition, using glucosyltransferases (GTs) to achieve glycosylation has become an emerging method for industrial glycoside production. 41 Ma et al developed probe 12 for the real-time monitoring of glucoside transfer (Fig.…”
Section: Biocatalytic Glucoside Transfermentioning
confidence: 99%